Ranbaxy Laboratories Ltd. v. United States Food & Drug Administration

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• adopting the FDA’s argument that “[approvals do not become effective by operation of law because the FDA has an ongoing health and safety responsibility to perform, and an applicant has no vested right to enter the market until the FDA gives its final formal approval”

Source: CourtListener parenthetical corpus (CC0).